Archive - February 2018
NHS could claw back £502m if Lyrica ruling upheld, study finds
AZ/MSD’s Lynparza wins new CHMP nod
Pharma’s first ‘performance marketing’ agency launched
Five new medicines backed for EU approval
Bayer announces publication of larotrectinib data in The New England Journal of Medicine
Anarchists attack Novartis office in Athens
India regulator reorgs, changes leader
5 Physical Manifestations Of Anxiety Disorders